Guoping Ren
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 12
- Prostate Cancer Diagnosis and Treatment 6
-
- Cancer-related gene regulation 4
- Ubiquitin and proteasome pathways 2
- RNA Research and Splicing 2
- Co-authors
- Yong‐Jie Lu (6 shared papers)Xueying Mao (6 shared papers)Daniel M. Berney (6 shared papers)Elzbieta Stankiewicz (5 shared papers)Jili Wang (8 shared papers)Xiaoyan Liu (8 shared papers)Jimin Shao (3 shared papers)Sakunthala C. Kudahetti (3 shared papers)
- Journals
- Cancer Medicine (2 papers)Frontiers in Oncology (2 papers)Oncotarget (2 papers)BMC Cancer (2 papers)Medicine (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Guoping Ren
38 papers receiving 674 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 166
- Pulmonary and Respiratory Medicine 265
- Oncology 140
- Obstetrics and Gynecology 29
- Molecular Biology 221
Countries citing papers authored by Guoping Ren
This map shows the geographic impact of Guoping Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoping Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoping Ren more than expected).
Fields of papers citing papers by Guoping Ren
This network shows the impact of papers produced by Guoping Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoping Ren. The network helps show where Guoping Ren may publish in the future.
Co-authors
The 25 scholars most cited alongside Guoping Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 130 | |
| 2 | 2015 | 121 | |
| 3 | 2012 | 39 | |
| 4 | 2015 | 39 | |
| 5 | 2019 | 34 | |
| 6 | 2006 | 27 | |
| 7 | 2017 | 21 | |
| 8 | Chinese and Western prostate cancers show alternate pathogenetic pathways in association with ERG status. | 2012 | 21 |
| 9 | 2017 | 20 | |
| 10 | 2021 | 19 | |
| 11 | 2011 | 17 | |
| 12 | 2020 | 17 | |
| 13 | 2019 | 17 | |
| 14 | 2018 | 16 | |
| 15 | 2019 | 15 | |
| 16 | 2018 | 14 | |
| 17 | 2019 | 12 | |
| 18 | 2020 | 11 | |
| 19 | High frequency of the SDK1:AMACR fusion transcript in Chinese prostate cancer. | 2015 | 11 |
| 20 | 2021 | 7 |
About Guoping Ren
Guoping Ren is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 41 papers that have together received 681 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (12 papers), Prostate Cancer Diagnosis and Treatment (6 papers), Cancer, Lipids, and Metabolism (5 papers), Cancer-related gene regulation (4 papers), Ubiquitin and proteasome pathways (2 papers), Urologic and reproductive health conditions (2 papers), Metal-Catalyzed Oxygenation Mechanisms (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Cancer Research (166 citations), Pulmonary and Respiratory Medicine (265 citations), Oncology (140 citations), Obstetrics and Gynecology (29 citations) and Molecular Biology (221 citations). Guoping Ren has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yong‐Jie Lu, Xueying Mao, Daniel M. Berney, Elzbieta Stankiewicz, Jili Wang, Xiaoyan Liu, Jimin Shao, Sakunthala C. Kudahetti, Lijun Zhu and Jing Shen. Their work appears in journals such as Cancer Medicine, Frontiers in Oncology, Oncotarget, BMC Cancer and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.